Decursin from Angelica gigas suppresses RANKL-induced osteoclast formation and bone loss
- Authors
- Wang, Xin; Zheng, Ting; Kang, Ju-Hee; Li, Hua; Cho, Hyewon; Jeon, Raok; Ryu, Jae-Ha; Yim, Mijung
- Issue Date
- Mar-2016
- Publisher
- ELSEVIER SCIENCE BV
- Keywords
- Angelica gigas; Decursin; Osteoclast; NFATc1; c-Fos; Bone loss
- Citation
- European Journal of Pharmacology, v.774, pp 34 - 42
- Pages
- 9
- Journal Title
- European Journal of Pharmacology
- Volume
- 774
- Start Page
- 34
- End Page
- 42
- URI
- https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/9901
- DOI
- 10.1016/j.ejphar.2016.01.008
- ISSN
- 0014-2999
1879-0712
- Abstract
- Osteoclasts are the only cells capable of breaking down bone matrix, and excessive activation of osteoclasts is responsible for bone-destructive diseases. In this study, we investigated the effects of decursin from extract of Angelica gigas root on receptor activator of nuclear factor kappa B ligand (RANKL)-induced osteoclast formation using mouse bone marrow-derived macrophages (BMMs). Decursin inhibited RANKL-induced osteoclast formation without cytotoxicity. In particular, decursin maintains the characteristics of macrophages by blocking osteoclast differentiation by RANKL. Furthermore, the RANKL-stimulated bone resorption was diminished by decursin. Mechanistically, decursin blocked the RANKL-triggered ERK mitogen-activated protein kinases (MAPK) phosphorylation, which results in suppression of c-Fos and the nuclear factor of activated T cells (NFATc1) expression. In accordance with the in vitro study, decursin reduced lipopolysaccharide (LPS)- or ovariectomy (OVX)-induced bone loss in vivo. Therefore, decursin exerted an inhibitory effect on osteoclast formation and bone loss in vitro and in vivo. Decursin could be useful for the treatment of bone diseases associated with excessive bone resorption. (C) 2016 Elsevier B.V. All rights reserved.
- Files in This Item
-
Go to Link
- Appears in
Collections - 약학대학 > 약학부 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.